GLAXOSMITHKLINE DEMONSTRATES PROGRESS OF ONCOLOGY PORTFOLIO

A A

GlaxoSmithKline will present new data across a broad, innovative portfolio of experimental cancer medicines and vaccines at the annual American Society of Clinical Oncology (ASCO) meeting in Atlanta starting Friday, June 2nd.

Financial News USA (http://www.financialnewsusa.com/release.php?rlsid=5246)